CG Oncology, Inc. Common stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 02/14/2025 | 6.37 M | $182.74 M | 16.30% | 9.49% |
| VANGUARD GROUP INC | 02/11/2025 | 5.86 M | $168.10 M | 15.34% | 8.73% |
| BLACKROCK, INC. | 02/07/2025 | 4.06 M | $116.47 M | 13.73% | 6.05% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 3.67 M | $105.26 M | 0.00% | 5.47% |
| BRAIDWELL LP | 02/14/2025 | 3.28 M | $94.17 M | 3.55% | 4.89% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 2.52 M | $72.27 M | 42.29% | 3.75% |
| FMR LLC | 02/13/2025 | 2.43 M | $69.80 M | 1,571.35% | 3.62% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 2.22 M | $63.71 M | 100.00% | 3.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 1.91 M | $54.79 M | 274.44% | 2.85% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.82 M | $52.14 M | 61.60% | 2.71% |
| RTW INVESTMENTS, LP | 02/14/2025 | 1.70 M | $48.79 M | 26.57% | 2.53% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 1.49 M | $42.62 M | -2.67% | 2.21% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.46 M | $41.82 M | 18,836.00% | 2.17% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.43 M | $41.04 M | 107.07% | 2.13% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.28 M | $36.59 M | 3.71% | 1.90% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1.17 M | $33.53 M | 263.84% | 1.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.16 M | $33.18 M | 7.25% | 1.72% |
| 02/14/2025 | 1.13 M | $32.45 M | 100.00% | 1.69% | |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 1.10 M | $31.48 M | -33.71% | 1.64% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 967,055 | $27.74 M | 0.00% | 1.44% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 945,194 | $27.11 M | 59.82% | 1.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 851,593 | $24.42 M | 0.11% | 1.27% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 818,667 | $23.48 M | 26.03% | 1.22% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 775,000 | $22.23 M | -20.51% | 1.15% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 770,000 | $22.08 M | 0.00% | 1.15% |
| MORGAN STANLEY | 02/14/2025 | 725,227 | $20.80 M | 208.78% | 1.08% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 700,000 | $20.08 M | 0.00% | 1.04% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 02/14/2025 | 692,550 | $19.86 M | 0.00% | 1.03% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 674,607 | $19.35 M | 100.00% | 1.00% |
| WOODLINE PARTNERS LP | 02/14/2025 | 628,885 | $18.04 M | 3.79% | 0.94% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 593,262 | $17.01 M | 14.06% | 0.88% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/03/2025 | 546,904 | $15.69 M | 25.13% | 0.81% |
| ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD | 02/14/2025 | 495,526 | $14.21 M | 0.00% | 0.74% |
| NORTHERN TRUST CORP | 02/14/2025 | 433,860 | $12.44 M | 13.74% | 0.65% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 427,760 | $12.27 M | 12.67% | 0.64% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 419,450 | $12.03 M | -42.83% | 0.62% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 328,585 | $9.42 M | -3.52% | 0.49% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 308,259 | $8.84 M | -58.68% | 0.46% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 257,157 | $7.38 M | -8.14% | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 249,001 | $7.14 M | 100.00% | 0.37% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 236,108 | $6.77 M | -23.66% | 0.35% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 224,582 | $6.44 M | -2.52% | 0.33% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 224,580 | $6.44 M | 100.00% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 215,750 | $6.19 M | 50.76% | 0.32% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 209,518 | $6.01 M | 22.60% | 0.31% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 200,000 | $5.74 M | -50.00% | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 197,937 | $5.68 M | -1.02% | 0.29% |
| 02/13/2025 | 181,582 | $5.21 M | 100.00% | 0.27% | |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 174,048 | $4.99 M | -33.89% | 0.26% |
| YU FAN | 02/14/2025 | 163,456 | $1.28 M | 0.00% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CG Oncology, Inc. Common stock institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of CG Oncology, Inc. Common stock. The most heavily invested institutionals were:
Parallel Advisors, LLC: 0
Decheng Capital LLC: 6.37 M
VANGUARD GROUP INC: 5.86 M
BlackRock, Inc.: 4.06 M
TCG Crossover Management, LLC: 3.67 M
BRAIDWELL LP: 3.28 M
95.76% of CG Oncology, Inc. Common stock stock is owned by institutional investors.
Institutional investors have bought a total of 63.43 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.